IDEXX LABORATORIES INC /DE Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent of -$25.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-03.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent · last filed 2025-11-03
- IDEXX LABORATORIES INC /DE other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax, attributable to parent for the quarter ending 2025-09-30 was -$25.00K.
- IDEXX LABORATORIES INC /DE other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax, attributable to parent for the quarter ending 2025-06-30 was -$24.00K.
- IDEXX LABORATORIES INC /DE other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax, attributable to parent for the quarter ending 2025-03-31 was -$22.00K.
- IDEXX LABORATORIES INC /DE other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax, attributable to parent for the quarter ending 2024-09-30 was -$21.00K.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2025-09-30 | -$25.00K 10-Q · filed 2025-11-03 | -$49.00K derived: sum of 2 quarters · filed 2025-11-03 | -$71.00K 10-Q · filed 2025-11-03 |
| 2025-06-30 | -$24.00K 10-Q · filed 2025-08-04 | -$46.00K 10-Q · filed 2025-08-04 | |
| 2025-03-31 | -$22.00K 10-Q · filed 2025-05-01 | ||
| 2024-09-30 | -$21.00K 10-Q · filed 2025-11-03 | -$31.00K derived: sum of 2 quarters · filed 2025-11-03 | -$50.00K 10-Q · filed 2025-11-03 |
| 2024-06-30 | -$10.00K 10-Q · filed 2025-08-04 | -$29.00K 10-Q · filed 2025-08-04 | |
| 2024-03-31 | -$19.00K 10-Q · filed 2025-05-01 | ||
| 2023-09-30 | -$21.00K 10-Q · filed 2024-10-31 | -$55.00K derived: sum of 2 quarters · filed 2024-10-31 | -$75.00K 10-Q · filed 2024-10-31 |
| 2023-06-30 | -$34.00K 10-Q · filed 2024-08-06 | -$54.00K 10-Q · filed 2024-08-06 | |
| 2023-03-31 | -$20.00K 10-Q · filed 2024-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |